Skip to main content
. 2012 Oct 1;7(10):e45750. doi: 10.1371/journal.pone.0045750

Table 3. Characteristics of treatment-naïve HIV-infected adults: comparison of HBsAg+veHBV DNA+ve versus HBsAg-ve HBV DNA+ve individualsa.

Characteristic HBV DNA+ve participants (n = 71) HBsAg+veHBV DNA+ve (n = 26) HBsAg-ve HBV DNA+ve (n = 45) Significance–p valuesb
All Male[A] Female[A] All[D] Male[B] Female[B] All[D] Male[C] Female[C] A B C D
Numbers (%) 71 30(42%) 41(58%) 26 13(50%) 13(50%) 45 17(38%) 28(62%) n/a 0.42 0.54 n/a
Age in years 35(28–41) 37(34–47) 31(25–39) 34(27–28) 35(33–39) 29(25–35) 36(29–45) 38 (35–47) 34(28–40) 0.01 0.07 0.035 0.14
Age at sexual debut in years c 17(16–18) 17(16–19) 16(15–18) 17(16–20) 18(16–22) 17(15–18) 16(15–18) 17(16–18) 16(15–18) 0.12 0.11 0.66 0.23
Lifetime sexual partners d 3(2–5) 4(2–8) 3(2–5) 3(1–6) 2(1–6) 3(1–5) 4(2–5) 4(2–10) 3(2–5) 0.34 0.98 0.17 0.38
BMI in kg m−2 22(20–24) 21(20–23) 22(20–25) 23(20–25) 22(20–23) 25(20–27) 21(20–23) 21(20–22) 22(20–24) 0.37 0.29 0.64 0.30
ALT in U L−1 23(15–37) 31(18–59) 20(12–28) 30(19–59) 35(22–60) 21(12–39) 20(13–32) 27(15–37) 19(13–25) 0.027 0.29 0.12 0.07
Apoptosense U L−1 114(91–158) 117(91–160) 114(91–152) 113(84–156) 110(75–150) 114(91–161) 114(94–158) 121(96–188) 114(91–142) 0.96 0.27 0.37 0.62
CD4 cells mm−3 148(74–199) 104(60–171) 180(103–245) 152 (101–202) 125 (98–184) 179 (132–255) 147(68–196) 87(57–165) 181(91–229) 0.006 0.13 0.016 0.52
LogHBVVL e 3.72(3.04–4.41) 3.76(2.95–4.47) 3.61(3.08–4.35) 3.64(2.73–4.80) 4.14(2.74–5.44) 3.22(2.54–4.01) 3.78(3.15–4.35) 3.74(2.99–4.28) 3.81(3.19–4.44) 0.66 0.14 0.59 0.74
a

all values expressed as “Median (Interquartile Range)”.

b

comparing the columns marked by UPPER case letter; statistical significance is indicated by underlining.

c

9 samples without data points omitted.

d

2 samples without data points omitted.

e

“LogHBVVL” indicates the log of the HBV viral load rounded to two decimal places [A Mann-Whitney U test was used on the untransformed viral loads (IU ml−1)].